Our Pipeline

What We Are Achieving

Bioval’s product pipeline includes programs using vectorized antibody approach targeting tauopathies, such as Alzheimer’s disease. For each of these diseases, there is an important need for novel therapeutic solutions. Depending on the disease, our gene therapies will use gene knockdown, gene replacement, or our vectorized antibody approach. By significantly balancing the production of relevant proteins at targeted sites within the central nervous system, the aim is to make a meaningful impact on patients’ quality of life.